Biotherapeutics Virus Removal Filters Market Outlook (2023 to 2033)

Global biotherapeutics virus removal filters market demand is anticipated to be valued at USD 451.2 million in 2023. It is forecasted to thrive at a CAGR of 8.0% from 2023 to 2033, reaching a market valuation of USD 972.6 million by 2033.

Growth is attributed to the pre-determined risk of contamination in biotherapeutic products and technological advancement in healthcare. From 2018 to 2022, a CAGR of 5.8% was registered for this market.

Attributes Details
Biotherapeutics Virus Removal Filters Market Share (2022) USD 424.3 million
Biotherapeutics Virus Removal Filters Market Share (2023) USD 451.2 million
Biotherapeutics Virus Removal Filters Market Share (2033) USD 972.6 million
Biotherapeutics Virus Removal Filters Market Share (2023 to 2033) 8.0%

The biotherapeutics virus removal filters can be used either in vivo or in-vitro environments. In biotherapeutics virus removal filtration, the virus removability is based on a size-exclusion mechanism that is those viruses that are superior to the mean pore size, became trapped.

The biotherapeutics virus removal filters are basically used during the manufacturing of biotherapeutic drug products or samples such as therapeutic replacement enzymes, antibodies, blood, derivatives of plasma, and biopharmaceuticals. The pre-determined risk of contamination in biotherapeutic products is the major factor that can upsurge the growth of the biotherapeutics virus removal filters market.

North America is expected to dominate the biotherapeutics virus removal filter market due to the advent of advanced technologies in this region. Overall, the global biotherapeutics virus removal filters market is expected to show significant growth over a forecast period.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are Some Prominent Drivers Spearheading Biotherapeutics Virus removal filters Market Growth?

Increasing awareness about the benefits of using biotherapeutics virus removal filters among healthcare professionals and consumers fuelling the demand for the biotherapeutics virus removal filters market.

Technological advancements in filter design and manufacturing improve performance, reduce costs, and increase efficiency will boost the growth of the market in the forecasting period. The rising incidence of infectious diseases and growing investments in healthcare infrastructure development provide lucrative opportunities to the market.

What are the Challenges Faced by the Biotherapeutics Virus removal filters Industry?

Although the biotherapeutics virus removal filters market has numerous end-uses, there are numerous obstacles that likely pose a challenge to market growth. Lack of technical expertise and lack of awareness may impede the growth of the biotherapeutics virus removal filter market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Why is North America Emerging as an Opportunistic Biotherapeutics Virus removal filter Market?

North America was the largest market for the biotherapeutics virus removal filters market and the trend is expected to continue into the forecast period owing to the increasing number of research going on monoclonal antibodies (mAb) and recombinant protein, which require virus removal filters.

North America is expected to be the next dominant region witnessing high adoption rates for the biotherapeutics virus removal filters market during the forecast period.

The technological advancement in the healthcare sector in the region is expected to augment the biotherapeutics virus removal filter market. The region is forecasted to have a 33.2% share of the biotherapeutics virus removal filters market.

How is Europe Contributing to the Growth of the Biotherapeutics Virus removal filters Market?

According to Future Market Insights Europe is expected to hold the second-largest market share in the global biotherapeutics virus removal filters market due to the advanced medical facilities and easy availability of the biotherapeutics virus removal filters in the market in the region.

Europe is predicted to account for a total 29.5% share in the global biotherapeutics virus removal filters market.

Increasing healthcare investments and the presence of prominent market vendors and providers also benefit Europe’s market. The global biotherapeutics virus removal filter market is gaining traction in the region due to increasing research facilities and the developing biopharmaceutical industry.

Some stringent government regulations in Germany and France in terms of approval, restrain the growth of this market in the European region.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

The Start-up Ecosystem: How are Key Players helping Shape Demand?

Despite the threat of the COVID-19 pandemic having subsided, there is a lingering apprehension about contracting the infection through direct and indirect means. Hence, healthcare providers are making sure their facilities are properly sanitized and rendered germ-free.

This is the widening of the uptake of biotherapeutics virus removal filters to a large extent. Here are some notable start-ups operating within this domain.

Company Name Spry Therapeutics
Origin United States
Year of Establishment 2018
Company Name BioLife
Origin Canada
Year of Establishment 2004
Company Name MDI Membrane Technologies
Origin United States
Year of Establishment 2014
Company Name Flow Filters
Origin Canada
Year of Establishment 2007
Company Name Agentis Air
Origin United States
Year of Establishment 2019
Company Name FilterEasy
Origin United States
Year of Establishment 2012
Company Name Pacific Air Filtration
Origin United States
Year of Establishment 2014
  • In December 2020, Spry Therapeutics entered into a strategic partnership with Healthcare Surfaces Institute to further its quest to mitigate the incidence rates of hospital-acquired infections. The partnership is aimed at reducing the transmission of surface-borne pathogens, including viruses, by eliminating the smallest superbugs- as little as .02 microns.
  • BioLife Sciences Corp is a developer of antimicrobial solutions protecting against viruses, bacteria & pathogens. It has developed disruptive technologies for the healthcare, beauty, food, and beverage industry sectors. It uses antimicrobial copper air filters designed to clean air and fight against airborne bacteria & viruses. It provides ultraviolet sterilization devices that offer disinfectant solutions and also provide warning alarms.

Competitive Landscape

Some of the key participants present in the global biotherapeutics virus removal filters market includes Pall Corporation, Z-Medica, LLC, Asahi Kasei Corporation, Merck KGaA, and Sartorius AG among others.

Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Pall Corporation, Z-Medica, LLC, and Asahi Kasei Corporation account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in the Asia Pacific.

  • In April 2022- Merck, announced an advancement in its bioprocessing portfolio with the acquisition of the MAST® The acquisition of the MAST® platform adds fully automated sampling to the bioprocessing portfolio.
  • In December 2021- Asahi Kasei Medical Co., Ltd. announced the acquisition of Bionique Testing Laboratories LLC (Bionique).

Key Players in the Global Market

  • Pall Corporation
  • Z-Medica LLC
  • Asahi Kasei Corporation
  • Merck KGaA
  • Sartorius AG

Scope of the Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis USD Million for Value
Key Regions Covered North America; Latin America; Europe; Asia Pacific; Middle East & Africa (MEA)
Key Countries Covered United States, Canada, Germany, United Kingdom, Nordic, Russia, BENELUX, Poland, France, Spain, Italy, Czech Republic, Hungary, Rest of EMEAI, Brazil, Peru, Argentina, Mexico, South Africa, Northern Africa, GCC Countries, China, Japan, South Korea, India, ASEAN, Thailand, Malaysia, Indonesia, Australia, New Zealand, Others
Key Segments Covered Technology, Application, End-user, Region
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Trend Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Biotherapeutics Virus Removal Filters Market Segmentation

By Technology:

  • Size Exclusion Technology
  • Depth Filtration Technology

By Application:

  • Monoclonal Antibodies
  • Blood & Plasma
  • Enzymes
  • Proteins

By End-user:

  • Biopharmaceutical Companies
  • Clinical Research Organizations
  • Academic Institutions
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Frequently Asked Questions

What is the Projected CAGR of the Biotherapeutics Virus removal filters Market by 2033?

The projected CAGR of the Biotherapeutics Virus removal filters Market by 2033 is 8%.

What is the Projected Biotherapeutics Virus removal filters Market value for 2033?

The projected market value for 2033 is USD 972.6 million.

What is the Current Market Valuation of the Biotherapeutics Virus removal filters Market?

The market is estimated to secure a valuation of USD 451.2 million in 2023.

Which Industry is the Key Consumer of the Biotherapeutics Virus removal filters Market?

The food and beverage industry are the key consumer of the Biotherapeutics Industry.

Table of Content
	1. Executive Summary
	2. Market Overview
	3. Market Background
	4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
	5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology
		5.1. Size Exclusion Technology
		5.2. Depth Filtration Technology
	6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
		6.1. Monoclonal Antibodies
		6.2. Blood & Plasma
		6.3. Enzymes
		6.4. Proteins
	7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
		7.1. Biopharmaceutical Companies
		7.2. Clinical Research Organizations
		7.3. Academic Institutes
		7.4. Other End Users
	8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
		8.1. North America
		8.2. Latin America
		8.3. Western Europe
		8.4. Eastern Europe
		8.5. South Asia and Pacific
		8.6. East Asia
		8.7. Middle East and Africa
	9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
	16. Key Countries Market Analysis
	17. Market Structure Analysis
	18. Competition Analysis
		18.1. Pall Corporation
		18.2. Z-Medica, LLC
		18.3. Asahi Kasei Corporation
		18.4. Merck KGaA
		18.5. Sartorius AG
		18.6. EMD Millipore
		18.7. Thermo Fisher Scientific Inc
		18.8. GE Healthcare
		18.9. Lonza Group Ltd
		18.10. Entegris, Inc.
	19. Assumptions & Acronyms Used
	20. Research Methodology
Recommendations

Healthcare

Pediatric Respiratory Syncytial Virus Infection Market

January 2023

REP-GB-2345

250 pages

Healthcare

Human Respiratory Syncytial Virus (RSV) Treatment Market

November 2022

REP-GB-1553

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Biotherapeutics Virus removal filters Market

Schedule a Call